USC/Norris Comprehensive Cancer Center
USC/Norris
About USC/Norris
Patient Care
Research
Clinical Trials
Search Trials
Faculty
Education
Future at USC/Norris
Core Facilities
Support USC/Norris
» Contact Us
» Glossary
» Make a Donation
If you are a patient, please contact
The Doctors of USC
at 800-USC-CARE.
Details for trial 4K-08-5
Description:
A Randomized, Open-Label, Multi-Center Phase II Study to Compare Bevacizumab plus RAD001 versus Interferon Alpha-2a plus Bevacizumab for the First-Line Treatment of Patients with Metastatic Clear Cell Carcinoma of the Kidney.
Status:
Open
Randomized?
Yes
Researchers
Principal Investigator
Title
David Quinn
M.D.
Data Management
Name
Title
Lagrimas Ilagan
D.M.
Jolie Solomon
R.N.
Roberto Tejada
D.M.
Carrie Korn
R.N.
Kristy Sartor Massopust
R.N.
You may participate in this study if:
(No criteria found)
You may not participate in this study if:
(No criteria found)
For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.
